An orthotopic lung tumor model for image-guided microirradiation in rats

Radiation Research

Volumn 174, Issue 1, 2010, Pages 62-71

  Saha, Debabrata ^a   Watkins, Linda ^a   Yin, Yi ^a   Thorpe, Philip ^a   Story, Michael D ^a   Song, Kwang ^a   Raghavan, Pavithra ^a   Timmerman, Robert ^a   Chen, Benjamin ^a   Minna, John D ^b   Solberg, Timothy D ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BAVITUXIMAB; PHOSPHATIDYLSERINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN BINDING; ARTICLE; BIOLUMINESCENCE; CANCER CELL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IRRADIATION; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MALE; MICRO-COMPUTED TOMOGRAPHY; NONHUMAN; NUDE RAT; PRIORITY JOURNAL; RADIATION DOSE; RADIATION RESPONSE; RAT; STEREOTACTIC BODY RADIATION THERAPY; TUMOR GROWTH; TUMOR LOCALIZATION; TUMOR MODEL; TUMOR VASCULARIZATION;

ANIMALS; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE MODELS, ANIMAL; IMMUNOHISTOCHEMISTRY; LUMINESCENCE; LUNG NEOPLASMS; NEOPLASM TRANSPLANTATION; RATS; RATS, NUDE; TOMOGRAPHY, X-RAY COMPUTED;

ANIMALIA; RATTUS;

EID: 77954511814     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR2157.1     Document Type: Article

References (36)

1. L. A. G. Ries, D. Melbert, M. Krapcho, D. G. Stinchcomb, N. Howlader, M. J. Horner, A. Mariotto, B. A. Miller, E. J. Feuer and B. K. Edwards, Eds., SEER Cancer Statistics Review, 1975-2005. National Cancer Institute, Bethesda, MD, http://seer. cancer.gov/csr/1975-2005/, based on November 2007 SEER data submission, posted to the SEER website, 2008.
2. B. J. Flehinger, M. Kimmel and M. R. Melamed, The effect of surgical treatment on survival from early lung cancer. Implications for screening. Chest 101, 1013-1018 (1992).
3. N. W. Gale and G. D. Yancopoulos, Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development. Genes Dev. 13, 1055-1066 (1999).
4. J. G. Armstrong and B. D. Minsky, Radiation therapy for medically inoperable stage I and II non-small cell lung cancer. Cancer Treat. Rev. 16, 247-255 (1989).
5. P. Coy and G. M. Kennelly, The role of curative radiotherapy in the treatment of lung cancer. Cancer 45, 698-702 (1980).
6. D. E. Dosoretz, M. J. Katin, P. H. Blitzer, J. H. Rubenstein, D. H. Galmarini, G. R. Garton and S. A. Salenius, Medically inoperable lung carcin ma: the role of radiation therapy. Semin. Radiat. Oncol. 6, 98-104 (1996).
7. D. E. Dosoretz, M. J. Katin, P. H. Blitzer, J. H. Rubenstein, S. Salenius, M. Rashid, R. A. Dosani, G. Mestas, A. D. Siegel and T. T. Chadha, Radiation therapy in the management of medically inoperable carcinoma of the lung: results and implications for future treatment strategies. Int. J. Radiat. Oncol. Biol. Phys. 24, 3-9 (1992).
8. B. G. Haffty, N. B. Goldberg, J. Gerstley, D. B. Fischer and R. E. Peschel, Results of radical radiation therapy in clinical stage I, technically operable non-small cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 15, 69-73 (1988).
9. L. Kaskowitz, M. V. Graham, B. Emami, K. J. Halverson and C. Rush, Radiation therapy alone for stage I non-small cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 27, 517-523 (1993).
10. G. S. Sibley, T. A. Jamieson, L. B. Marks, M. S. Anscher and L. R. Prosnitz, Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: the Duke experience. Int. J. Radiat. Oncol. Biol. Phys. 40, 149-154 (1998).
11. A. Pirzkall, J. Debus, F. Lohr, M. Fuss, B. Rhein, R. Engenhart-Cabillic and M. Wannenmacher, Radiosurgery alone or in combination with whole-brain radiotherapy for brain metastases. J. Clin. Oncol. 16, 3563-3569 (1998).
12. J. M. Varlotto, J. C. Flickinger, A. Niranjan, A. K. Bhatnagar, D. Kondziolka and L. D. Lunsford, Analysis of tumor control and toxicity in patients who have survived at least one year after radiosurgery for brain metastases. Int. J. Radiat. Oncol. Biol. Phys. 57, 452-464 (2003).
13. K. K. Herfarth, J. Debus, F. Lohr, M. L. Bahner, P. Fritz, A. Hoss, W. Schlegel and M. F. Wannenmacher, Extracranial stereotactic radiation therapy: set-up accuracy of patients treated for liver metastases. Int. J. Radiat. Oncol. Biol. Phys. 46, 329-335 (2000).
14. I. Lax, H. Blomgren, I. Naslund and R. Svanstrom, Stereotactic radiotherapy of malignancies in the abdomen. Methodological aspects. Acta Oncol. 33, 677-683 (1994).
15. L. Papiez, R. Timmerman, C. DesRosiers and M. Randall, Extracranial stereotactic radioablation: physical principles. Acta Oncol. 42, 882-894 (2003).
16. M. Uematsu, M. Sonderegger, A. Shioda, K. Tahara, T. Fukui, Y. Hama, T. Kojima, J. R. Wong and S. Kusano, Daily positioning accuracy of frameless stereotactic radiation therapy with a fusion of computed tomography and linear accelerator (focal) unit: evaluation of z-axis with a z-marker. Radiother. Oncol. 50, 337-339 (1999).
17. J. Wulf, U. Haedinger, U. Oppitz, W. Thiele, G. Mueller and M. Flentje, Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: A noninvasive treatment approach in medically inoperable patients. Int. J. Radiat. Oncol. Biol. Phys. 60, 186-196 (2004).
18. H. Blomgren, I. Lax, I. Naslund and R. Svanstrom, Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients. Acta Oncol. 34, 861-870 (1995).
19. K. K. Herfarth, J. Debus, F. Lohr, M. L. Bahner, B. Rhein, P. Fritz, A. Hoss, W. Schlegel and M. F. Wannenmacher, Stereotactic single-dose radiation therapy of liver tumors: results of a phase I/II trial. J. Clin. Oncol. 19, 164-170 (2001).
20. R. D. Timmerman, K. M. Forster and L. Chinsoo Cho, Extracranial stereotactic radiation delivery. Semin. Radiat. Oncol. 15, 202-207 (2005).
21. R. D. Timmerman and B. D. Kavanagh, Stereotactic body radiation therapy. Curr. Probl. Cancer 29, 120-157 (2005).
22. R. D. Timmerman, C. Park and B. D. Kavanagh, The North American experience with stereotactic body radiation therapy in non-small cell lung cancer. J. Thorac. Oncol. 2, S101-S112 (2007).
23. J. He, T. A. Luster and P. E. Thorpe, Radiation-enhanced vascular targeting of human lung cancers in mice with a monoclonal antibody that binds anionic phospholipids. Clin. Cancer Res. 13, 5211-5218 (2007).
24. Z. G. Dikmen, G. C. Gellert, S. Jackson, S. Gryaznov, R. Tressler, P. Dogan, W. E. Wright and J. W. Shay, In vivo inhibition of lung cancer by GRN163L: a novel human telomerase inhibitor. Cancer Res. 65, 7866-7873 (2005).
25. S. Ran and P. E. Thorpe, Phosphatidylserine is a marker of tumor vasculature and a potential target for cancer imaging and therapy. Int. J. Radiat. Oncol. Biol. Phys. 54, 1479-1484 (2002).
26. A. Marconescu and P. E. Thorpe, Coincident exposure of phosphatidylethanolamine and anionic phospholipids on the surface of irradiated cells. Biochim. Biophys. Acta 1778, 2217-2224 (2008).
27. S. Burma, B. P. Chen, M. Murphy, A. Kurimasa and D. J. Chen, ATM phosphorylates histone H2AX in response to DNA double-strand breaks. J. Biol. Chem. 276, 42462-42467 (2001).
28. J. Kobayashi, H. Tauchi, B. Chen, S. Burma, S. Tashiro, S. Matsuura, K. Tanimoto, D. J. Chen and K. Komatsu, Histone H2AX participates the DNA damage-induced ATM activation through interaction with NBS1. Biochem. Biophys. Res. Commun. 380, 752-757 (2009).
29. A. K. Das, M. Sato, M. D. Story, M. Peyton, R. Graves, S. Redpath, L. Girard, A. F. Gazdar, J. W. Shay and C. S. Nirodi, Non-small-cell lung cancers with kinase domain mutations in the epidermal growth factor receptor are sensitive to ionizing radiation. Cancer Res. 66, 9601-9608 (2006).
30. E. Kodym, R. Kodym, A. E. Reis, A. A. Habib, M. D. Story and D. Saha, The small-molecule CDK inhibitor, SNS-032, enhances cellular radiosensitivity in quiescent and hypoxic non-small cell lung cancer cells. Lung Cancer 66, 37-47 (2009).
31. T. Yamaura, Y. Doki, K. Murakami and I. Saiki, Model for mediastinal lymph node metastasis produ ed by orthotopic intrapulmonary implantation of lung cancer cells in mice. Hum. Cell 12, 197-204 (1999).
32. A. Onn, T. Isobe, S. Itasaka, W. Wu, M. S. O'Reilly, W. Ki Hong, I. J. Fidler and R. S. Herbst, Development of an orthotopic model to study the biology and therapy of primary human lung cancer in nude mice. Clin. Cancer Res. 9, 5532-5539 (2003).
33. T. H. March, P. G. Marron-Terada and S. A. Belinsky, Refinement of an orthotopic lung cancer model in the nude rat. Vet. Pathol. 38, 483-490 (2001).
34. R. W. Byhardt, U. A. Almagro, B. L. Fish and J. E. Moulder, Development of a rat lung cancer model. Int. J. Radiat. Oncol. Biol. Phys. 10, 2125-2130 (1984).
35. W. D. McElroy, Properties of the reaction utilizing adenosinetri- phosphate for bioluminescence. J. Biol. Chem. 191, 547-557 (1951).
36. O. Szentirmai, C. H. Baker, N. Lin, S. Szucs, M. Takahashi, S. Kiryu, A. L. Kung, R. C. Mulligan and B. S. Carter, Noninvasive bioluminescence imaging of luciferase expressing intracranial U87 xenografts: correlation with magnetic resonance imaging determined tumor volume and longitudinal use in assessing tumor growth and antiangiogenic treatment effect. Neurosurgery 58, 365-372 (2006).